Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soichiro Shibui

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Brain Tumor Pathology|March 16, 2013
Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomasMakoto Ohno, Yoshitaka Narita, Yasuji Miyakita, et al.
Molecular and Clinical Oncology|March 21, 2014
Clinical presentation of anaplastic large-cell lymphoma in the central nervous systemMasashi Nomura, Yoshitaka Narita, Yasuji Miyakita, et al.
Neurologia Medico-Chirurgica|July 1, 2010
Pure germinoma of the pineal gland with synchronous spinal dissemination--case reportMasaya Nagaishi, Ryotaro Suzuki, Yoshihiro Tanaka, et al.
Clinical Neurology and Neurosurgery|March 27, 2012
Long-term follow-up of vanishing tumors in the brain: how should a lesion mimicking primary CNS lymphoma be managed?Yoshiko Okita, Yoshitaka Narita, Yasuji Miyakita, et al.
Brain Tumor Pathology|March 19, 2013
Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiationShintaro Fukushima, Akihiko Yoshida, Kazufumi Honda, et al.
Journal of Neuro-Oncology|December 17, 2009
Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphomaHiroyuki Momota, Yoshitaka Narita, Akiko M Maeshima, et al.
Brain Tumor Pathology|October 22, 2013
Short communication: sclerosing meningioma in the deep sylvian fissureShintaro Fukushima, Yoshitaka Narita, Motoki Yonezawa, et al.
Stem Cell Research|November 5, 2013
Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cellsAtsushi Sato, Masashi Okada, Keita Shibuya, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|February 15, 2013
A case of more than 20 years survival with glioblastoma, and development of cavernous angioma as a delayed complication of radiotherapyShintaro Fukushima, Yoshitaka Narita, Yasuji Miyakita, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomasHideyuki Arita, Yoshitaka Narita, Hirokazu Takami, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Brain Tumor Pathology|March 16, 2013
Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomasMakoto Ohno, Yoshitaka Narita, Yasuji Miyakita, et al.
Molecular and Clinical Oncology|March 21, 2014
Clinical presentation of anaplastic large-cell lymphoma in the central nervous systemMasashi Nomura, Yoshitaka Narita, Yasuji Miyakita, et al.
Neurologia Medico-Chirurgica|July 1, 2010
Pure germinoma of the pineal gland with synchronous spinal dissemination--case reportMasaya Nagaishi, Ryotaro Suzuki, Yoshihiro Tanaka, et al.
Clinical Neurology and Neurosurgery|March 27, 2012
Long-term follow-up of vanishing tumors in the brain: how should a lesion mimicking primary CNS lymphoma be managed?Yoshiko Okita, Yoshitaka Narita, Yasuji Miyakita, et al.
Brain Tumor Pathology|March 19, 2013
Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiationShintaro Fukushima, Akihiko Yoshida, Kazufumi Honda, et al.
Journal of Neuro-Oncology|December 17, 2009
Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphomaHiroyuki Momota, Yoshitaka Narita, Akiko M Maeshima, et al.
Brain Tumor Pathology|October 22, 2013
Short communication: sclerosing meningioma in the deep sylvian fissureShintaro Fukushima, Yoshitaka Narita, Motoki Yonezawa, et al.
Stem Cell Research|November 5, 2013
Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cellsAtsushi Sato, Masashi Okada, Keita Shibuya, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|February 15, 2013
A case of more than 20 years survival with glioblastoma, and development of cavernous angioma as a delayed complication of radiotherapyShintaro Fukushima, Yoshitaka Narita, Yasuji Miyakita, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomasHideyuki Arita, Yoshitaka Narita, Hirokazu Takami, et al.
Pageof 10